Tolterodine Tartrate Capsule, Extended Release
Product Images NDC 0904-7575

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 0904-7575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4mg Carton Label (E4b9ef09 C750 4e35 96fc E759ba4849d8 00)

This text is the label information for Major brand Tolterodine Tartrate Extended-release Capsules. Each capsule contains 4 mg of tolterodine tartrate. It provides guidelines for dosage, storage instructions, and safety precautions. The product is intended for institutional use only and should be kept out of reach of children. Refer to the product insert for full prescribing information.*

FDA Label Image

2mg Carton Label (E4b9ef09 C750 4e35 96fc E759ba4849d8 01)

This is a description of a medication labeled as Tolterodine Tartrate Extended-release Capsules, USP. Each capsule contains 2 mg of Tolterodine Tartrate USP. The recommended dosage and usage information are provided in the product insert. The storage conditions require keeping the medication at 25°C (77°F) with excursions permitted to 15-30°C (59-86°F). It is essential to protect the medication from light and keep it out of the reach of children. The package is not child-resistant and is intended for institutional use only. The medication is distributed by Major Pharmaceuticals in Indianapolis, IN, USA.*

FDA Label Image

Tolterodine-01 (D996a5c0 Db7e 4c41 9628 A2a4f9227af4 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.